Prenatal And Newborn Genetic Testing Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Prenatal And Newborn Genetic Testing Market?
Support and initiatives by the government for prenatal testing and newborn genetic screening are anticipated to accelerate the expansion of the prenatal and newborn genetic testing markets. When referring to government initiatives, we mean particular actions, programs, policies, or projects implemented by the government at local, regional, or national levels to address a specific problem, pursue definite objectives, or enhance citizen welfare. Prenatal and newborn genetic testing governmental initiatives help the population of the country by assisting in the early detection of genetic conditions or abnormalities in fetal stages during pregnancy or shortly after a baby’s birth. For example, in June 2022, the New South Wales newborn screening program in Australia received annual funding of $1.3 million from the government to provide free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), including newborn genetic tests and screenings, to all newborns in the state. The screening tests are expected to be given to approximately 100,000 babies annually, potentially saving the lives of up to 13 newborns likely to have these genetic conditions. Therefore, these government initiatives and support for prenatal testing and newborn genetic screening influence the growth of prenatal and newborn genetic testing markets.
The Growth in the Prenatal And Newborn Genetic Testing Market Driven by the Increasing Rate of Genetic Disorders
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
#How Will the CAGR of the Prenatal And Newborn Genetic Testing Market Influence Its Overall Growth by 2034?
The market size for prenatal and newborn genetic testing has seen a substantial surge in the recent past. It is set to increase from a value of $6.68 billion in 2024 to $7.61 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.9%. The historical growth can be associated with advancements in non-invasive prenatal testing, a rise in maternal age, governmental backing, healthcare policies, and a growing expectation from patients for early detection.
In the coming years, the market size of prenatal and newborn genetic testing is projected to experience substantial growth. The anticipated figure for 2029 stands at $12.04 billion, with a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period is linked to factors such as broader genetic test panels, heightened awareness of maternal health, guidelines for prenatal and newborn screening, increased attention to rare diseases and ethical and regulatory considerations. The significant trends during this forecast period encompass non-invasive prenatal testing (NIPT), whole genome sequencing (WGS) and whole exome sequencing, artificial intelligence (AI) integration, preimplantation genetic testing (PGT), and direct consumer genetic testing.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158
What Are the Most Significant Market Trends Transforming thePrenatal And Newborn Genetic Testing Market?
Leading businesses in prenatal and newborn genetic testing sector are channeling efforts toward the creation of innovative screening tests, such as noninvasive prenatal screening tests, with enhanced affordability and access in order to render dependable services to clientele. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening procedure conducted during pregnancy to evaluate the risk of particular fetal chromosomal abnormalities. For instance, in November 2022, a healthcare technology firm from the US, Juno Diagnostics Inc., introduced Juno Hazel. This noninvasive prenatal screening test identifies chromosomal anomalies and furnishes clinical data. The test deployes a sample collection kit, abolishing the need for phlebotomy, thereby boosting accessibility. The company is set to avail instructional resources and customised genetic counselling assistance in collaboration with doctors and genetic advisors.
What Are the Top Market Players Propelling the Growth of thePrenatal And Newborn Genetic Testing Industry?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Prenatal And Newborn Genetic Testing Market Are Driving Growth and Industry Transformations?
The prenatal and newborn genetic testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Prenatal And Newborn Genetic Testing Market?# Market?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2025, By The Business Research Company:
Non-invasive Prenatal Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Antimicrobial Susceptibility Testing Global Market Report 2024
Prenatal Testing & Newborn Screening Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
